Simultaneous measurement of the major metabolites of dolasetron mesilate in human urine using solid-phase extraction and high-performance liquid chromatography
- 4 November 1994
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 661 (1) , 101-107
- https://doi.org/10.1016/s0378-4347(94)80054-5
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Human dolasetron pharmacokinetics: II Absorption and disposition following single‐dose oral administration to normal male subjectsBiopharmaceutics & Drug Disposition, 1993
- Dolasetron mesylateDrugs of the Future, 1993
- Pharmacological properties of dolasetron, a potent and selective antagonist at 5‐HT3 receptorsDrug Development Research, 1993
- Human dolasetron pharmacokinetics: I. Disposition following single‐dose intravenous administration to normal male subjectsBiopharmaceutics & Drug Disposition, 1992
- Characterization of the novel 5-HT3 antagonists MDL 73147EF (dolasetron mesilate) and MDL 74156 in NG108-15 neuroblastoma × glioma cellsEuropean Journal of Pharmacology, 1992
- Cytoplasmic Aldo-Keto Reductases: A Class of Drug Metabolizing EnzymesScience, 1976